Part 29 - CONTROLLED SUBSTANCE PRESCRIPTION MONITORING PROGRAM
- Section 16.19.29.1 - ISSUING AGENCY
- Section 16.19.29.2 - SCOPE
- Section 16.19.29.3 - STATUTORY AUTHORITY
- Section 16.19.29.4 - DURATION
- Section 16.19.29.5 - EFFECTIVE DATE
- Section 16.19.29.6 - OBJECTIVE
- Section 16.19.29.7 - DEFINITIONS
- Section 16.19.29.8 - MANDATORY REPORTING OF PRESCRIPTION INFORMATION TO THE PMP
- Section 16.19.29.9 - DISCLOSURE OF PRESCRIPTION INFORMATION
- Section 16.19.29.10 - DISCLOSURE OF AUDIT TRAIL INFORMATION
- Section 16.19.29.11 - AUTHORITY TO CONTRACT
- Section 16.19.29.12 - REGISTRATION FOR ACCESS TO PRESCRIPTION INFORMATION
- Section 16.19.29.13 - INFORMATION EXCHANGE WITH OTHER PRESCRIPTION MONITORING PROGRAMS
- Section 16.19.29.14 - PENALTIES
- Section 16.19.29.15 - SEVERABILITY